These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21817114)

  • 1. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
    Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shogaol overcomes TRAIL resistance in colon cancer cells via inhibiting of survivin.
    Hwang JS; Lee HC; Oh SC; Lee DH; Kwon KH
    Tumour Biol; 2015 Nov; 36(11):8819-29. PubMed ID: 26063410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
    Gupta SC; Reuter S; Phromnoi K; Park B; Hema PS; Nair M; Aggarwal BB
    J Biol Chem; 2011 Jan; 286(2):1134-46. PubMed ID: 21078664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species.
    Yodkeeree S; Sung B; Limtrakul P; Aggarwal BB
    Cancer Res; 2009 Aug; 69(16):6581-9. PubMed ID: 19654295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.
    Shin EA; Sohn EJ; Won G; Choi JU; Jeong M; Kim B; Kim MJ; Kim SH
    Oncotarget; 2014 Jul; 5(14):5624-36. PubMed ID: 25015549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors.
    Shoeb M; Ramana KV; Srivastava SK
    Free Radic Biol Med; 2013 Oct; 63():280-90. PubMed ID: 23732517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers.
    Kim J; Yun M; Kim EO; Jung DB; Won G; Kim B; Jung JH; Kim SH
    Br J Pharmacol; 2016 Mar; 173(6):1033-44. PubMed ID: 26661339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal carcinoma cell targeting aromatherapy with Teucrium ramosissimum essential oil to sensitize TRAIL/Apo2L-induced HCT-116 cell death.
    Guesmi F; Tahri W; Mehrez A; Barkaoui T; Prasad S; Giuffrè AM; Landoulsi A
    Int Immunopharmacol; 2024 Jul; 136():112405. PubMed ID: 38850792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy.
    Han L; Dai S; Li Z; Zhang C; Wei S; Zhao R; Zhang H; Zhao L; Shan B
    J Exp Clin Cancer Res; 2019 Dec; 38(1):501. PubMed ID: 31864387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins.
    Prasad S; Ravindran J; Sung B; Pandey MK; Aggarwal BB
    Mol Cancer Ther; 2010 Apr; 9(4):856-68. PubMed ID: 20371723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis.
    Yoshida T; Shiraishi T; Horinaka M; Nakata S; Yasuda T; Goda AE; Wakada M; Mizutani Y; Miki T; Nishikawa A; Sakai T
    Cancer Sci; 2007 Sep; 98(9):1417-23. PubMed ID: 17645780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.
    Oikonomou E; Kothonidis K; Taoufik E; Probert E; Zografos G; Nasioulas G; Andera L; Pintzas A
    Br J Cancer; 2007 Jul; 97(1):73-84. PubMed ID: 17551494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro studies on the role of regulating Smac expression in the occurrence and development of colon cancer.
    Zhang D; Yang N
    Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):206-210. PubMed ID: 38836659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumors.
    Lee S; Yagita H; Sayers TJ; Celis E
    Cancer Immunol Immunother; 2010 Jul; 59(7):1073-81. PubMed ID: 20213120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells.
    Kaler P; Galea V; Augenlicht L; Klampfer L
    PLoS One; 2010 Jul; 5(7):e11700. PubMed ID: 20661477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer.
    Khawaja H; Campbell A; Roberts JZ; Javadi A; O'Reilly P; McArt D; Allen WL; Majkut J; Rehm M; Bardelli A; Di Nicolantonio F; Scott CJ; Kennedy R; Vitale N; Harrison T; Sansom OJ; Longley DB; Evergren E; Van Schaeybroeck S
    Cell Death Dis; 2020 Oct; 11(10):930. PubMed ID: 33122623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Antidepressant Drug Increased TRAIL Receptor-2 Expression and Sensitized Lung Cancer Cells to TRAIL-induced Apoptosis.
    Zinnah KMA; Newaz Munna A; Seol JW; Park BY; Park SY
    Anticancer Agents Med Chem; 2023; 23(20):2225-2236. PubMed ID: 37859313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL-Sensitizing Effects of Flavonoids in Cancer.
    Luiz-Ferreira A; Pacifico T; Cruz ÁC; Laudisi F; Monteleone G; Stolfi C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells.
    Romeo C; Weber MC; Zarei M; DeCicco D; Chand SN; Lobo AD; Winter JM; Sawicki JA; Sachs JN; Meisner-Kober N; Yeo CJ; Vadigepalli R; Tykocinski ML; Brody JR
    Mol Cancer Res; 2016 Jul; 14(7):599-611. PubMed ID: 27053682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL of Hope Meeting Resistance in Cancer.
    Deng D; Shah K
    Trends Cancer; 2020 Dec; 6(12):989-1001. PubMed ID: 32718904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.